Resistin is associated with the inflammation process in patients with systemic autoimmune diseases undergoing glucocorticoid therapy: comparison with leptin and adiponectin

References

• Lago F, Dieguez C, Gómez-Reino J, Gualillo 0. Adipokines as emerging mediators of immune response and inflammation. Nat Clin Pract Rheumatol. 2007;3:716–24.
   Web of Science ®Google Scholar
• Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444:847–53.
   PubMed Web of Science ®Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18:499–502.
   Google Scholar
• Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, et al. Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract. 2002;55:65–85.
   PubMed Web of Science ®Google Scholar
• Kumeda Y, Inaba M, Goto H, Nagata M, Henmi Y, Furumitsu Y, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum. 2002;46:1489–97.
   PubMed Web of Science ®Google Scholar
• Bertouch JV, Roberts-Thompson PJ, Feng PH, Bradley J. C-reactive protein and serological indices of disease activity in systemic lupus erythematosus. Ann Rheum Dis. 1983;42:655–8.
   PubMed Web of Science ®Google Scholar
• Gabay C, Gay-Croisier F, Roux-Lombard P, Meyer 0, Maineti C, Guerne PA, et al. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response. Arthritis Rheum. 1994;37: 1744–51.
   Google Scholar
• Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med. 2008;121: S3–8.
   PubMed Web of Science ®Google Scholar
• Svenungsson E, Jensen-Urstad K, Heimbfirger M, Silveira A, Hamsten A, de Faire U, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation. 2001;104: 1887–93.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Juanatey C, Lopez-Diaz MJ, Martin J, Llorca J, Gonzalez-Gay MA. Atherosclerosis in patients with biopsy-proven giant cell arteritis. Arthritis Rheum. 2007;57:1481–6.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115–26.
   PubMed Web of Science ®Google Scholar
• Cho Y, Lee SE, Lee HC, Hur J, Lee S, Youn SW, et al. Adipokine resistin is a key player to modulate monocytes, endothelial cells, and smooth muscle cells, leading to progression of atheroscle-rosis in rabbit carotid artery. J Am Coll Cardiol. 2010;57:99–109.
   Web of Science ®Google Scholar
• Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307–12.
   PubMed Web of Science ®Google Scholar
• Patel L, Buckels AC, Kinghom IJ, Murdock PR, Holbrook JD, Plumpton C, et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003;300:472–6.
   PubMed Web of Science ®Google Scholar
• Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal mus-cle. Biochem Biophys Res Commun. 2001;285:561–4.
   PubMed Web of Science ®Google Scholar
• Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes. 2001;50: 2199–202.
   Google Scholar
• Kunnari AM, Savolainen ER, Ukkola OH, Kesdniemi YA, Jokela MA. The expression of human resistin in different leucocyte lineages is modulated by LPS and TNFalpha. Regul Pept. 2009; 157:57–63.
   Google Scholar
• Chung CP, Long AG, Solus JF, Rho YH, Oeser A, Raggi P, et al. Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus. 2009;18:799–806.
   PubMed Web of Science ®Google Scholar
• De Sanctis JB, Zabaleta M, Bianco NE, Garmendia JV, Rivas L. Serum adipokine levels in patients with systemic lupus erythe-matosus. Autoimmunity. 2009;42:272–4.
   Google Scholar
• Vadacca M, Margiotta D, Rigon A, Cacciapaglia F, Coppolino G, Amoroso A, et al. Adipokines and systemic lupus erythematosus: relationship with metabolic syndrome and cardiovascular disease risk factors. J Rheumatol. 2009;36:295–7.
   PubMed Web of Science ®Google Scholar
• Kemmotsu Y, Saji T, Kusunoki N, Tanaka N, Nishimura C, Ishiguro A, et al. Serum adipokine profiles in Kawasaki disease. Mod Rheumatol. 2012;22:66–72.
   PubMed Web of Science ®Google Scholar
• Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2004;1:e45.
   PubMed Web of Science ®Google Scholar
• Shyu KG, Chua SK, Wang BW, Kuan P. Mechanism of inhibi-tory effect of atorvastatin on resistin expression induced by tumor necrosis factor-alpha in macrophages. J Biomed Sci. 2009;16:50.
   PubMed Web of Science ®Google Scholar
• Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI. Resistin competes with lipopolysaccharide for binding to Toll-like receptor 4. J Cell Mol Med. 2010;14:1419–31.
   PubMed Web of Science ®Google Scholar
• Singh AK, Battu A, Mohareer K, Hasnain SE, Ehtesham NZ. Transcription of human resistin gene involves an interaction of Spl with peroxisome proliferator-activating receptor gamma (PPARgamma). PLoS One. 2010;5:e9912.
   Google Scholar
• Rhen T, Cidlowski JA. Antiinflammatory action of glucocorti-coids-new mechanisms for old drugs. N Engl J Med. 2005;353: 1711–23.
   PubMed Web of Science ®Google Scholar
• Al M, Ng L, Tyrrell P, Bargman J, Bradley T, Silverman E. Adipokines as novel biomarkers in paediatric systemic lupus erythematosus. Rheumatology (Oxf). 2009;48:497–501.
   PubMed Web of Science ®Google Scholar
• Sada KE, Yamasaki Y, Maruyama M, Sugiyama H, Yamamura M, Maeshima Y, et al. Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol. 2006;33:1545–52.
   PubMed Web of Science ®Google Scholar
• Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IC, Cardona-Mufioz EG, Salazar-Paramo M, González-Ortiz M, et al. Serum leptin levels in women with systemic lupus erythematosus. Rheumatol Int. 2002;22:138–41.
   PubMed Web of Science ®Google Scholar
• Wislowska M, Rok M, Stepiefi K, Kuklo-Kowalska A. Serum leptin in systemic lupus erythematosus. Rheumatol Int. 2008;28: 467–73.
   Google Scholar
• Kfimpers P, Horn R, Brabant G, Woywodt A, Schiffer M, Haller H, et al. Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis. Rheumatology (Oxf). 2008;47: 484–7.
   PubMed Web of Science ®Google Scholar
• Bruun JM, Pedersen SB, Kristensen K, Richelsen B. Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol. 2002; 190(1-2):91–9.
   PubMed Web of Science ®Google Scholar
• Zhang HH, Kumar S, Barnett AH, Eggo MC. Tumour necrosis factor-alpha exerts dual effects on human adipose leptin synthesis and release. Mol Cell Endocrinol. 2000;159:79–88.
   PubMed Web of Science ®Google Scholar
• Yamaguchi M, Murakami T, Tomimatsu T, Nishio Y, Mitsuda N, Kanzaki T, et al. Autocrine inhibition of leptin production by tumor necrosis factor-alpha (TNF-alpha) through TNF-alpha type-I receptor in vitro. Biochem Biophys Res Commun. 1998; 244:30–4.
   PubMed Web of Science ®Google Scholar
• Papaspyrou-Rao S, Schneider SH, Petersen RN, Fried SK. Dexamethasone increases leptin expression in humans in vivo. J Clin Endocrinol Metab. 1997;82:1635–7.
   PubMed Web of Science ®Google Scholar
• Newcomer JW, Selke G, Melson AK, Gross J, Vogler GP, Dagogo-Jack S. Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans. Arch Gen Psy-chiatry. 1998;55:995–1000.
   Google Scholar
• Masuzaki H, Ogawa Y, Hosoda K, Miyawaki T, Hanaoka I, Hiraoka J, et al. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome. J Clin Endocrinol Metab. 1997;82:2542–7.
   PubMed Web of Science ®Google Scholar
• Gong DW, Bi S, Pratley RE, Weintraub BD. Genomic structure and promoter analysis of the human obese gene. J Biol Chem. 1996;271:3971–4.
   PubMed Web of Science ®Google Scholar
• Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, dia-betes, and the metabolic syndrome. J Clin Invest. 2006;116: 1784–92.
   PubMed Web of Science ®Google Scholar
• Haugen F, Drevon CA. Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology. 2007;148:5478–86.
   PubMed Web of Science ®Google Scholar
• Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003;285:E527–33.
   PubMed Web of Science ®Google Scholar
• Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vase Biol. 2004; 24:29–33.
   PubMed Web of Science ®Google Scholar
• Tervaert JW. Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis. Clin Exp Immunol. 2009;156:377–85.
   PubMed Web of Science ®Google Scholar
• Tyrrell PN, Beyene J, Feldman BM, McCrindle BW, Silverman ED, Bradley TJ. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler 'Thromb Vase Biol. 2010;30:1014–26.
   PubMed Web of Science ®Google Scholar
• Rieth N, Jollin L, Le Panse B, Lecoq AM, Arlettaz A, De Ceauniz J, et al. Effects of short-term corticoid ingestion on food intake and adipokines in healthy recreationally trained men. Eur J Appl Physiol. 2009;105:309–13.
   Google Scholar
• Jong C, Inder WJ, Obeyesekere VR, Alford FP. Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone. Clin Endocrinol (Oxf). 2008;69:745–50.
   PubMed Web of Science ®Google Scholar
• Smoak K, Cidlowski JA. Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory ignaling. Mol Cell Biol. 2006;26:9126–35.
   PubMed Web of Science ®Google Scholar